Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Prepare Now to Survive MACRA

Kelly Tyrrell  |  Issue: July 2016  |  July 5, 2016

At present, “three out of the four [MIPS categories] can be achieved by RISE,” says Dr. Kazi, also a rheumatologist at the University of Texas Southwestern Medical Center. “It can facilitate population management and figure out who the patients are that are neediest or most expensive; eventually, it can be used for resource utilization and practice improvement activities. … We would grow it if the membership demands it. The vendors are ready to manage the demand.”

As a QCDR, RISE taps into electronic health records and captures the entirety of a practice’s patient population; thus, physicians using it don’t need to take extra steps for reporting through the MIPS pathway. RISE is valuable because rheumatologists are too small a market for information technology vendors to create additional carve-outs, says Dr. Adams.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“You can measure the quality of your work across many clinical quality measures and compare your performance against your practice partners and regional and national peers,” says Dr. Kazi, who adds that, in terms of MACRA, “We have a recipe for this, but we haven’t cooked the meal yet. We have patient numbers, ZIP codes, practice size, insurance information, all of which can provide elements needed to benchmark the cost of episodes of care each year.”

And RISE presents rheumatologists the chance to chart their own course on the MACRA sea.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We really need to demonstrate the value of rheumatology by having our own information, so we’re not dependent on others defining what’s important,” Dr. Kazi says. “If we do it ourselves, it gives us a voice we don’t otherwise have, backed by data and numbers.”

Other Opportunities
In addition to adapting RISE, Dr. White says the ACR is exploring other opportunities for rheumatologists in a new reimbursement environment. For example, although the Bundled Payments for Care Improvement Initiative (BPCI) is not currently a qualified APM, Dr. White says he suspects “the concept behind it will drive emerging APMs as we move forward, especially in subspecialty diseases.”

For example, a rheumatologist may receive a fixed sum to care for a patient in their first year following a rheumatoid arthritis diagnosis. “But we need a lot more information before we can figure out what’s tenable and what’s not,” Dr. White adds.

Or rheumatologists may consider a specialized medical home model, which could potentially be considered by CMS as an APM. Rheumatologists would need to assume accountability for patient-level outcomes and spending, since rheumatology patients have chronic, lifelong illness and “rheumatologists function as primary care physicians” for many of them, Dr. White says.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Professional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)MACRAMedicareRISE

Related Articles

    How to Survive MACRA

    April 19, 2017

    The year 2015 brought the end of the much-maligned Sustainable Growth Rate (SGR), sometimes known as the “doc fix.” The SGR established limits on Medicare reimbursement for physicians, and each year, physicians and those lobbying on their behalf were forced to stave off drastic cuts to their payments. “The SGR was Congress’s attempt to control…

    MACRA Has Arrived—& What You Do Now Counts

    October 4, 2017

    Changes to reimbursement introduced by the Medicare Access and CHIP Reauthorization Act (MACRA) will affect your Medicare income for 2019. “Rheumatologists generally know that MACRA is up and running,” says Angus Worthing, MD, FACR, FACP, clinical assistant professor of rheumatology at Georgetown University Medical Center and chair of the ACR’s Government Affairs Committee. “Virtually every…

    Medicare Access and CHIP Reauthorization Act of 2015: What You Should Know

    April 15, 2016

    There is no denying that the past few years have been a time of immense change in healthcare. Sweeping pieces of legislation have fundamentally altered the way we practice medicine. This is absolutely the case when it comes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, for short). MACRA is an enormous…

    MACRA: More Points, Smarter Future

    December 14, 2016

    As the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is implemented in January with new models for quality-based reimbursement payments, rheumatologists must seize control of how they will be paid now—and in the future. This message was stressed by speakers during Holy MACRA! How to Survive and Thrive in the Era of MACRA,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences